A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist) Meeting Abstract


Authors: Slovin, S. F.; Melloni, C.; Mansor-Lefebvre, S.; Neijber, A.; Roe, M.
Abstract Title: A multicenter, randomized, controlled trial comparing the occurrence of major adverse cardiovascular events (MACEs) in patients (pts) with prostate cancer (pc) and cardiovascular disease (CVD) receiving degarelix (GnRH receptor antagonist) or leuprolide (GnRH receptor agonist)
Meeting Title: 2018 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 6 Suppl.
Meeting Dates: 2018 Feb 8-10
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-20
Language: English
ACCESSION: WOS:000436179500389
DOI: 10.1200/JCO.2018.36.6_suppl.TPS395
PROVIDER: wos
Notes: Meeting Abstract: TPS395 -- Source: Wos
Altmetric Score
MSK Authors
  1. Susan Slovin
    178 Slovin